AAV |
Adeno-associated virus |
AC |
Adenocarcinoma |
ACTS |
Adoptive T-cell therapies |
AHR |
Aryl hydrocarbon receptor |
AIF |
Apoptosis inducible factor |
AIM-2 |
Absent in melanoma-2 |
AMP |
Antimicrobial peptides |
APC |
Antigen-presenting cell |
BECs |
Basal epithelial cells |
CAC |
Cervical adenocarcinoma |
CAR-T cell |
Chimeric antigen receptor T cell |
CC |
Cervical cancer |
CECs |
Cervical epithelial cells |
cGAMP |
Cyclic GMP-AMP |
cGAS |
cGMP-AMP synthase |
CIN |
Cervical intraepithelial neoplasia |
CLR |
C-type lectin receptors |
CMI |
Cell-mediated immunity |
CTL |
Cytotoxic T lymphocyte |
DNAM-1 |
DNAX accessory molecule-1 |
DGE |
Differential gene expression |
FoxP3 |
Forkhead box protein P3 |
FRT |
Female reproductive tract |
HIF |
Hypoxia-inducible factor |
HR-HPV |
High-risk HPV |
hTERT |
Human telomeres reverse transcriptase |
ICIs |
Immune checkpoint inhibitors |
IDO |
Indolamine dioxygenase |
LCs |
Langerhans cells |
MAIT |
Mucosal-associated invariant T |
MIP |
Macrophage inflammatory protein |
MUC |
Mucin |
NET |
Neutrophil extracellular trap |
NKCC |
NK-cell-mediated toxicity |
NKG2D |
Natural killer group 2D |
NLR |
Neutrophil lymphocyte ratio |
NOD |
Nucleotide-binding oligomerization domain |
PRR |
Pattern-recognition receptor |
RGS |
Regulator of G protein signaling |
RICK |
RIP-like interacting CLARP kinase |
SCC |
Squamous cell carcinoma |
SIL |
Squamous intraepithelial lesion |
STING |
Stimulating interferon genes |
TCR |
T-cell receptor |
TCR-T cells |
TCR-engineered/modified effector T cells |
TDO |
Tryptophan dioxygenase |
TIME |
Tumor immune microenvironment |
TME |
Tumor microenvironment |
TGF-β |
Transforming growth factor beta |
TSLP |
Thymic stromal lymphopoietin |
TZ |
Transformational Zone |
VISTA |
V-domain immunoglobulin suppressor of T cell activation |